Screener
Integra LifeSciences IART Rest of the World — Total long-lived assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The source filing: Integra LifeSciences’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:02 PM EST
- Fiscal year
- FY2025
- Accession
- 0000917520-26-000011
| Dollars in thousands | United States | Europe | Asia Pacific | Rest of the World | Consolidated |
|---|---|---|---|---|---|
| Total revenue, net: | |||||
| 2025 | $1,204,745 | $162,666 | $189,251 | $78,583 | $1,635,245 |
| 2024 | 1,192,675 | 158,496 | 176,614 | 82,742 | 1,610,527 |
| 2023 | 1,100,730 | 165,221 | 193,096 | 82,526 | 1,541,573 |
| Total long-lived assets: | |||||
| 2025 | 530,724 | 56,815 | 33,991 | 1,253 | 622,783 |
| 2024 | 534,336 | 52,385 | 28,264 | 1,295 | 616,280 |
| 2023 | 481,508 | 51,730 | 19,842 | 1,497 | 554,577 |
ITEM 16. FORM 10-K SUMMARY
FAQ
- What is Integra LifeSciences's rest of the world — total long-lived assets?
- Integra LifeSciences (IART) reported rest of the world — total long-lived assets of $1.25M in Q4 2025.
- What does rest of the world — total long-lived assets mean?
- Represents the total book value of non-current, tangible, and intangible assets physically located or managed within the geographic region designated as Rest of the World. This metric reflects the company's capital investment and infrastructure footprint outside of its primary domestic and major international markets. Monitoring this value helps investors assess the scale of operational capacity and long-term asset commitment in these specific territories.
Ask your AI about Integra LifeSciences's rest of the world — total long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude